EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group

Hetal Dholaria iD, Arlene Naranjo, Fan F Zhang iD, Wendy B London iD, Lisa Diller, Robert C Shamberger, Carol E Barnewolt, Mary Lou Schmidt, John M Maris iD, Sue L Cohn, Rochelle Bagatell iD, Jed G Nuchtern

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31829 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Hetal Dholaria und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Perth Children's Hospital, Perth, Australia. Hauptthemen laut MEDLINE: Neuroblastoma, Watchful Waiting. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCTN Statistics & Data Center, Chair's.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several studies have established that patients with localized perinatal neuroblastoma can be safely observed; however, long‐term outcomes have not been previously reported. We evaluated long‐term outcomes of infants with suspected perinatal neuroblastoma enrolled on the Children's Oncology Group (COG) ANBL00P2, which included an expectant observation approach. Among 87 eligible patients, the 10‐year event‐free survival (EFS) was 93.7%, and overall survival (OS) was 98.0%. Most tumors regressed spontaneously; only three patients reported progression to higher stage disease. This report reinforces the long‐term safety of non‐interventional management in perinatal neuroblastoma, sparing infants unnecessary surgery and associated risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaWatchful WaitingAdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleFollow-Up StudiesKaplan-Meier EstimatePrognosisSurvival RateTime FactorsMedical Oncology

Autor:innen und Institutionen

  • Department of Oncology, Perth Children's Hospital, Perth, Australia.
  • WA Kids Cancer Center, The Kids Research Institute Australia, Perth, Australia.
  • The University of Western Australia, Perth, Australia.
  • Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, Florida, USA.
  • Children's Oncology Group Statistics and Data Center, Monrovia, California, USA.
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.

ORCID-Profile: Hetal Dholaria, Fan F Zhang, Wendy B London, John M Maris, Rochelle Bagatell

Förderung

  • NCI NIH HHS
  • NCTN Statistics & Data Center
  • Chair's
  • NCTN Operations Center
  • Statistics & Data Center

Zitieren

APA

Dholaria, H., Naranjo, A., Zhang, F. F., London, W. B., Diller, L., Shamberger, R. C., Barnewolt, C. E., Schmidt, M. L., Maris, J. M., Cohn, S. L., Bagatell, R., & Nuchtern, J. G. (2025). Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31829

Vancouver

Dholaria H, Naranjo A, Zhang FF, London WB, Diller L, Shamberger RC, et al. Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31829

BibTeX
@article{Dholaria2025,
  author = {Dholaria, Hetal and Naranjo, Arlene and Zhang, Fan F and London, Wendy B and Diller, Lisa and Shamberger, Robert C and Barnewolt, Carol E and Schmidt, Mary Lou and Maris, John M and Cohn, Sue L and Bagatell, Rochelle and Nuchtern, Jed G},
  title = {Long‐Term Outcome of Young Infants With Suspected Neuroblastoma following Observation as Primary Therapy: A Report From the Children's Oncology Group},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31829}
}
Kostenlos starten →